Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AngloGold Ashanti PLCAU · Entity 3018 | Director | October 01, 2026 | October 02, 2026 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL · Entity 3398 | Director | May 08, 2026 | May 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AngloGold Ashanti PLC
Report date October 01, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table I · non-derivative | Direct | 967 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 967 · Balance 967 F1: Each restricted share unit represents a contingent right to receive one Ordinary Share upon vesting, at which time all restrictions on the vested shares will lapse, subject to the continued service of the Reporting Person through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted share unit represents a contingent right to receive one Ordinary Share upon vesting, at which time all restrictions on the vested shares will lapse, subject to the continued service of the Reporting Person through the applicable vesting date.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Report date May 08, 2026 · Filed May 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,384 |
Reported balance
After 2026-05-08 transaction · row 1
1 source rowRow 1 · 2026-05-08 · Grant · Acquired 1,438 · Balance 2,384 F1: The unvested restricted stock units vest upon the earlier of 5/8/2027 or the business day prior to the Company's next annual meeting of shareholders. |
Filing footnotes · ownership attribution and instrument terms
F1: The unvested restricted stock units vest upon the earlier of 5/8/2027 or the business day prior to the Company's next annual meeting of shareholders.
Past disclosures · reporting ended (4)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Arcadium Lithium plc
Report date March 06, 2025 · Filed March 06, 2025
Section 16 reporting ended · disclosed 2025-03-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-03-06 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2025-03-06 · Disposition to issuer · Disposed 332,275 · Balance 0 F1: Represents shares of common stock of Aracdium Lithium plc ("Arcadium") disposed of pursuant to the Transaction Agreement, dated October 9, 2024, by and among Arcadium, Rio Tinto Western Holdings Limited ("Parent") and Rio Tinto BM Subsidiary Limited ("Buyers") (the "Transaction Agreement"). Pursuant to the Transaction Agreement, at the effective time of the transaction contemplated thereby (the "Effective Time"), each share of Arcadium common stock held by the reporting person was converted automatically into the right to receive $5.85 per share in cash (the "Consideration"). |
| Ordinary SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-03-06 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2025-03-06 · Disposition to issuer · Disposed 1,010,204 · Balance 0 F2: Pursuant to the Transaction Agreement, at the Effective Time, each Arcadium restricted stock units ("Arcadium RSU") held by the reporting person and granted under the Arcadium Omnibus Incentive Plan was canceled in exchange for restricted stock units with respect to a number of ordinary shares of either Rio Tinto plc or Rio Tinto Limited ("Listed Shares") of equivalent value and with the same terms and conditions as applied to such Arcadium RSU immediately prior to the Effective Time ("Rio Tinto RSUs"). The number of Listed Shares subject to such Rio Tinto RSUs equals one multiplied by an exchange ratio of 0.0920493627351811, which equals the quotient obtained by dividing (i) the Consideration by (ii) the average volume weighted average price per ordinary share of the applicable Listed Share for the 30 consecutive trading day period ending on the last trading day preceding the Effective Time (the "Equity Award Conversion Ratio"). |
| Ordinary SharesSEC Table I · non-derivative | IndirectBy Savings Plan | 0 |
Reported balance
After 2025-03-06 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2025-03-06 · Disposition to issuer · Disposed 235,345 · Balance 0 F1: Represents shares of common stock of Aracdium Lithium plc ("Arcadium") disposed of pursuant to the Transaction Agreement, dated October 9, 2024, by and among Arcadium, Rio Tinto Western Holdings Limited ("Parent") and Rio Tinto BM Subsidiary Limited ("Buyers") (the "Transaction Agreement"). Pursuant to the Transaction Agreement, at the effective time of the transaction contemplated thereby (the "Effective Time"), each share of Arcadium common stock held by the reporting person was converted automatically into the right to receive $5.85 per share in cash (the "Consideration"). |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.95 · Expires 2034-03-06 | Direct | 0 |
Reported balance
After 2025-03-06 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-03-06 · Disposition to issuer · Disposed 1,013,599 · Balance 0 F3: Pursuant to the Transaction Agreement, at the Effective Time, each award of Arcadium stock options ("Arcadium Options") held by the reporting person and granted under the Arcadium Omnibus Incentive Plan was canceled in exchange for an award of stock options with respect to a number of Listed Shares of equivalent value and with the same terms and conditions as applied to such stock options immediately prior to the Effective Time ("Rio Tinto Options"). The number of Listed Shares subject to each such Rio Tinto Options equals the number of shares of Arcadium common stock subject to the corresponding Arcadium Options immediately prior to the Effective Time multiplied by the Equity Award Conversion Ratio. The exercise price of each such Rio Tinto Option equals the exercise price of the corresponding Arcadium Options divided by the Equity Award Conversion Ratio. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.45 · Expires 2027-02-27 | Direct | 0 |
Reported balance
After 2025-03-06 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2025-03-06 · Disposition to issuer · Disposed 311,098 · Balance 0 F3: Pursuant to the Transaction Agreement, at the Effective Time, each award of Arcadium stock options ("Arcadium Options") held by the reporting person and granted under the Arcadium Omnibus Incentive Plan was canceled in exchange for an award of stock options with respect to a number of Listed Shares of equivalent value and with the same terms and conditions as applied to such stock options immediately prior to the Effective Time ("Rio Tinto Options"). The number of Listed Shares subject to each such Rio Tinto Options equals the number of shares of Arcadium common stock subject to the corresponding Arcadium Options immediately prior to the Effective Time multiplied by the Equity Award Conversion Ratio. The exercise price of each such Rio Tinto Option equals the exercise price of the corresponding Arcadium Options divided by the Equity Award Conversion Ratio. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.10 · Expires 2028-02-15 | Direct | 0 |
Reported balance
After 2025-03-06 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2025-03-06 · Disposition to issuer · Disposed 200,520 · Balance 0 F3: Pursuant to the Transaction Agreement, at the Effective Time, each award of Arcadium stock options ("Arcadium Options") held by the reporting person and granted under the Arcadium Omnibus Incentive Plan was canceled in exchange for an award of stock options with respect to a number of Listed Shares of equivalent value and with the same terms and conditions as applied to such stock options immediately prior to the Effective Time ("Rio Tinto Options"). The number of Listed Shares subject to each such Rio Tinto Options equals the number of shares of Arcadium common stock subject to the corresponding Arcadium Options immediately prior to the Effective Time multiplied by the Equity Award Conversion Ratio. The exercise price of each such Rio Tinto Option equals the exercise price of the corresponding Arcadium Options divided by the Equity Award Conversion Ratio. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.07 · Expires 2028-10-10 | Direct | 0 |
Reported balance
After 2025-03-06 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2025-03-06 · Disposition to issuer · Disposed 320,801 · Balance 0 F3: Pursuant to the Transaction Agreement, at the Effective Time, each award of Arcadium stock options ("Arcadium Options") held by the reporting person and granted under the Arcadium Omnibus Incentive Plan was canceled in exchange for an award of stock options with respect to a number of Listed Shares of equivalent value and with the same terms and conditions as applied to such stock options immediately prior to the Effective Time ("Rio Tinto Options"). The number of Listed Shares subject to each such Rio Tinto Options equals the number of shares of Arcadium common stock subject to the corresponding Arcadium Options immediately prior to the Effective Time multiplied by the Equity Award Conversion Ratio. The exercise price of each such Rio Tinto Option equals the exercise price of the corresponding Arcadium Options divided by the Equity Award Conversion Ratio. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.07 · Expires 2028-10-10 | Direct | 0 |
Reported balance
After 2025-03-06 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2025-03-06 · Disposition to issuer · Disposed 320,799 · Balance 0 F3: Pursuant to the Transaction Agreement, at the Effective Time, each award of Arcadium stock options ("Arcadium Options") held by the reporting person and granted under the Arcadium Omnibus Incentive Plan was canceled in exchange for an award of stock options with respect to a number of Listed Shares of equivalent value and with the same terms and conditions as applied to such stock options immediately prior to the Effective Time ("Rio Tinto Options"). The number of Listed Shares subject to each such Rio Tinto Options equals the number of shares of Arcadium common stock subject to the corresponding Arcadium Options immediately prior to the Effective Time multiplied by the Equity Award Conversion Ratio. The exercise price of each such Rio Tinto Option equals the exercise price of the corresponding Arcadium Options divided by the Equity Award Conversion Ratio. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.70 · Expires 2033-02-22 | Direct | 0 |
Reported balance
After 2025-03-06 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2025-03-06 · Disposition to issuer · Disposed 143,525 · Balance 0 F3: Pursuant to the Transaction Agreement, at the Effective Time, each award of Arcadium stock options ("Arcadium Options") held by the reporting person and granted under the Arcadium Omnibus Incentive Plan was canceled in exchange for an award of stock options with respect to a number of Listed Shares of equivalent value and with the same terms and conditions as applied to such stock options immediately prior to the Effective Time ("Rio Tinto Options"). The number of Listed Shares subject to each such Rio Tinto Options equals the number of shares of Arcadium common stock subject to the corresponding Arcadium Options immediately prior to the Effective Time multiplied by the Equity Award Conversion Ratio. The exercise price of each such Rio Tinto Option equals the exercise price of the corresponding Arcadium Options divided by the Equity Award Conversion Ratio. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.74 · Expires 2032-02-23 | Direct | 0 |
Reported balance
After 2025-03-06 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2025-03-06 · Disposition to issuer · Disposed 145,870 · Balance 0 F3: Pursuant to the Transaction Agreement, at the Effective Time, each award of Arcadium stock options ("Arcadium Options") held by the reporting person and granted under the Arcadium Omnibus Incentive Plan was canceled in exchange for an award of stock options with respect to a number of Listed Shares of equivalent value and with the same terms and conditions as applied to such stock options immediately prior to the Effective Time ("Rio Tinto Options"). The number of Listed Shares subject to each such Rio Tinto Options equals the number of shares of Arcadium common stock subject to the corresponding Arcadium Options immediately prior to the Effective Time multiplied by the Equity Award Conversion Ratio. The exercise price of each such Rio Tinto Option equals the exercise price of the corresponding Arcadium Options divided by the Equity Award Conversion Ratio. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.46 · Expires 2031-02-22 | Direct | 0 |
Reported balance
After 2025-03-06 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2025-03-06 · Disposition to issuer · Disposed 482,431 · Balance 0 F3: Pursuant to the Transaction Agreement, at the Effective Time, each award of Arcadium stock options ("Arcadium Options") held by the reporting person and granted under the Arcadium Omnibus Incentive Plan was canceled in exchange for an award of stock options with respect to a number of Listed Shares of equivalent value and with the same terms and conditions as applied to such stock options immediately prior to the Effective Time ("Rio Tinto Options"). The number of Listed Shares subject to each such Rio Tinto Options equals the number of shares of Arcadium common stock subject to the corresponding Arcadium Options immediately prior to the Effective Time multiplied by the Equity Award Conversion Ratio. The exercise price of each such Rio Tinto Option equals the exercise price of the corresponding Arcadium Options divided by the Equity Award Conversion Ratio. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock of Aracdium Lithium plc ("Arcadium") disposed of pursuant to the Transaction Agreement, dated October 9, 2024, by and among Arcadium, Rio Tinto Western Holdings Limited ("Parent") and Rio Tinto BM Subsidiary Limited ("Buyers") (the "Transaction Agreement"). Pursuant to the Transaction Agreement, at the effective time of the transaction contemplated thereby (the "Effective Time"), each share of Arcadium common stock held by the reporting person was converted automatically into the right to receive $5.85 per share in cash (the "Consideration").
F2: Pursuant to the Transaction Agreement, at the Effective Time, each Arcadium restricted stock units ("Arcadium RSU") held by the reporting person and granted under the Arcadium Omnibus Incentive Plan was canceled in exchange for restricted stock units with respect to a number of ordinary shares of either Rio Tinto plc or Rio Tinto Limited ("Listed Shares") of equivalent value and with the same terms and conditions as applied to such Arcadium RSU immediately prior to the Effective Time ("Rio Tinto RSUs"). The number of Listed Shares subject to such Rio Tinto RSUs equals one multiplied by an exchange ratio of 0.0920493627351811, which equals the quotient obtained by dividing (i) the Consideration by (ii) the average volume weighted average price per ordinary share of the applicable Listed Share for the 30 consecutive trading day period ending on the last trading day preceding the Effective Time (the "Equity Award Conversion Ratio").
F3: Pursuant to the Transaction Agreement, at the Effective Time, each award of Arcadium stock options ("Arcadium Options") held by the reporting person and granted under the Arcadium Omnibus Incentive Plan was canceled in exchange for an award of stock options with respect to a number of Listed Shares of equivalent value and with the same terms and conditions as applied to such stock options immediately prior to the Effective Time ("Rio Tinto Options"). The number of Listed Shares subject to each such Rio Tinto Options equals the number of shares of Arcadium common stock subject to the corresponding Arcadium Options immediately prior to the Effective Time multiplied by the Equity Award Conversion Ratio. The exercise price of each such Rio Tinto Option equals the exercise price of the corresponding Arcadium Options divided by the Equity Award Conversion Ratio.
FMC CORP
Report date March 01, 2019 · Filed March 05, 2019
Section 16 reporting ended · disclosed 2019-03-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 68,087 |
Reported balance
After 2019-03-01 transaction · row 1
1 source rowRow 1 · 2019-03-01 · Disposition to issuer · Disposed 14,118 · Balance 68,087 F1: Represents the conversion of restricted stock units ("FMC RSUs") with respect to shares of common stock of FMC Corporation ("FMC"), par value $0.10 per share ("FMC Common Stock"), held by the Reporting Person as of March 1, 2019, into restricted stock units with respect to shares of common stock of Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent ("EMA") and the anti-dilution adjustment provisions under the FMC Incentive Compensation and Stock Plan ("FMC Plan"), in connection with the prorata spinoff distribution ("Distribution") by FMC of all of its shares of Livent Common Stock to the holders of record of FMC Common Stock on February 25, 2019. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $59.47 · Expires 2023-02-18 | Direct | 0 |
Reported balance
After 2019-03-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-03-01 · Disposition to issuer · Disposed 12,246 · Balance 0 F2: Represents the conversion of stock options to purchase FMC Common Stock ("FMC Options") into stock options to purchase Livent Common Stock ("Livent Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $72.93 · Expires 2024-02-17 | Direct | 0 |
Reported balance
After 2019-03-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-03-01 · Disposition to issuer · Disposed 10,252 · Balance 0 F2: Represents the conversion of stock options to purchase FMC Common Stock ("FMC Options") into stock options to purchase Livent Common Stock ("Livent Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $63.41 · Expires 2025-02-27 | Direct | 0 |
Reported balance
After 2019-03-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-03-01 · Disposition to issuer · Disposed 13,986 · Balance 0 F2: Represents the conversion of stock options to purchase FMC Common Stock ("FMC Options") into stock options to purchase Livent Common Stock ("Livent Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $57.63 · Expires 2027-02-27 | Direct | 0 |
Reported balance
After 2019-03-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-03-01 · Disposition to issuer · Disposed 18,591 · Balance 0 F2: Represents the conversion of stock options to purchase FMC Common Stock ("FMC Options") into stock options to purchase Livent Common Stock ("Livent Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $85.24 · Expires 2028-02-15 | Direct | 0 |
Reported balance
After 2019-03-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2019-03-01 · Disposition to issuer · Disposed 11,983 · Balance 0 F2: Represents the conversion of stock options to purchase FMC Common Stock ("FMC Options") into stock options to purchase Livent Common Stock ("Livent Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the conversion of restricted stock units ("FMC RSUs") with respect to shares of common stock of FMC Corporation ("FMC"), par value $0.10 per share ("FMC Common Stock"), held by the Reporting Person as of March 1, 2019, into restricted stock units with respect to shares of common stock of Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent ("EMA") and the anti-dilution adjustment provisions under the FMC Incentive Compensation and Stock Plan ("FMC Plan"), in connection with the prorata spinoff distribution ("Distribution") by FMC of all of its shares of Livent Common Stock to the holders of record of FMC Common Stock on February 25, 2019.
F2: Represents the conversion of stock options to purchase FMC Common Stock ("FMC Options") into stock options to purchase Livent Common Stock ("Livent Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution.
LYDALL INC /DE/
Report date October 01, 2021 · Filed October 05, 2021
Section 16 reporting ended · disclosed 2021-10-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-10-01 transaction · row 1
1 source rowRow 1 · 2021-10-01 · Disposition to issuer · Disposed 773 · Balance 0 F1: Disposed of as a result of the merger pursuant to the previously announced Agreement and Plan of Merger, dated as of June 21, 2021, by and among Lydall, Inc., Unifrax Holding Co., Outback Merger Sub, Inc. and Unifrax I LLC, as it may be amended from time to time, referred to as the Merger Agreement. F2: Each share of common stock was cancelled pursuant to the Merger Agreement in exchange for the right to receive $62.10 in cash per share. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of as a result of the merger pursuant to the previously announced Agreement and Plan of Merger, dated as of June 21, 2021, by and among Lydall, Inc., Unifrax Holding Co., Outback Merger Sub, Inc. and Unifrax I LLC, as it may be amended from time to time, referred to as the Merger Agreement.
F2: Each share of common stock was cancelled pursuant to the Merger Agreement in exchange for the right to receive $62.10 in cash per share.
Livent Corp.
Report date January 04, 2024 · Filed January 08, 2024
Section 16 reporting ended · disclosed 2024-01-08. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-01-04 transaction · row 1
1 source rowRow 1 · 2024-01-04 · Disposition to issuer · Disposed 355,541 · Balance 0 F1: Represents the conversion of common stock and restricted stock units ("Livent RSUs") with respect to shares of common stock of Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), held by the reporting person as of January 4, 2024, into ordinary shares and restricted stock units with respect to ordinary shares of Arcadium Lithium plc ("Arcadium"), par value $1.00 per share ("Arcadium Ordinary Shares"), in accordance with the terms of the Transaction Agreement, dated as of May 10, 2023, by and between Livent, Allkem Limited ("Allkem"), Lightning-A Merger Sub, Inc. and Arcadium, providing for a combination of Livent and Allkem in a merger of equals transaction. |
| Common StockSEC Table I · non-derivative | Indirectby Savings Plan | 0 |
Reported balance
After 2024-01-04 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2024-01-04 · Disposition to issuer · Disposed 97,815 · Balance 0 F2: Represents the conversion of common stock held by the Livent Nonqualified Savings Plan (the "Livent NQ Savings Plan") into Arcadium Ordinary Shares held by such Livent NQ Savings Plan, upon the assumption by Arcadium of the obligations of Livent under the Livent NQ Savings Plan in connection with the merger of equals transaction. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $23.33 · Expires 2033-02-22 | Direct | 0 |
Reported balance
After 2024-01-04 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-01-04 · Disposition to issuer · Disposed 59,653 · Balance 0 F3: Represents the conversion of stock options to purchase Livent Common Stock ("Livent Options") into stock options to purchase Arcadium Ordinary Shares ("Arcadium Options"), in accordance with the terms of the Transaction Agreement, in connection with the merger of equals transaction. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $21.01 · Expires 2032-02-23 | Direct | 0 |
Reported balance
After 2024-01-04 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-01-04 · Disposition to issuer · Disposed 60,628 · Balance 0 F3: Represents the conversion of stock options to purchase Livent Common Stock ("Livent Options") into stock options to purchase Arcadium Ordinary Shares ("Arcadium Options"), in accordance with the terms of the Transaction Agreement, in connection with the merger of equals transaction. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $20.35 · Expires 2031-02-22 | Direct | 0 |
Reported balance
After 2024-01-04 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2024-01-04 · Disposition to issuer · Disposed 200,512 · Balance 0 F3: Represents the conversion of stock options to purchase Livent Common Stock ("Livent Options") into stock options to purchase Arcadium Ordinary Shares ("Arcadium Options"), in accordance with the terms of the Transaction Agreement, in connection with the merger of equals transaction. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the conversion of common stock and restricted stock units ("Livent RSUs") with respect to shares of common stock of Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), held by the reporting person as of January 4, 2024, into ordinary shares and restricted stock units with respect to ordinary shares of Arcadium Lithium plc ("Arcadium"), par value $1.00 per share ("Arcadium Ordinary Shares"), in accordance with the terms of the Transaction Agreement, dated as of May 10, 2023, by and between Livent, Allkem Limited ("Allkem"), Lightning-A Merger Sub, Inc. and Arcadium, providing for a combination of Livent and Allkem in a merger of equals transaction.
F2: Represents the conversion of common stock held by the Livent Nonqualified Savings Plan (the "Livent NQ Savings Plan") into Arcadium Ordinary Shares held by such Livent NQ Savings Plan, upon the assumption by Arcadium of the obligations of Livent under the Livent NQ Savings Plan in connection with the merger of equals transaction.
F3: Represents the conversion of stock options to purchase Livent Common Stock ("Livent Options") into stock options to purchase Arcadium Ordinary Shares ("Arcadium Options"), in accordance with the terms of the Transaction Agreement, in connection with the merger of equals transaction.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 09, 2022 Filed Sep 13, 2022 16:04 UTC | Livent Corp. LTHM · Entity 95365 | Exercise / conversionStock Option (Right to Buy) · Derivative | 85,171 | $0.00 Strike: $8.56 | $0.00 |
DisclosureSEC source: 0001062993-22-019506 · form4.xml · derivative · entry 4 Graves Paul W · CIK 0001559551 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 85,171 shares Expires 2023-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 09, 2022 Filed Sep 13, 2022 16:04 UTC | Livent Corp. LTHM · Entity 95365 | SaleCommon Stock | 85,171 | $35.00 | $2,980,985.00 |
DisclosureSEC source: 0001062993-22-019506 · form4.xml · nonDerivative · entry 2 Graves Paul W · CIK 0001559551 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,980 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2020. Read SEC document |
| September 09, 2022 Filed Sep 13, 2022 16:04 UTC | Livent Corp. LTHM · Entity 95365 | Exercise / conversionCommon Stock | 85,171 | $8.56 | $729,063.76 |
DisclosureSEC source: 0001062993-22-019506 · form4.xml · nonDerivative · entry 1 Graves Paul W · CIK 0001559551 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 385,151 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 23:33 UTC | Livent Corp. LTHM · Entity 95365 | GrantStock Option (Right to Buy) · Derivative | 60,628 | $0.00 Strike: $21.01 | $0.00 |
DisclosureSEC source: 0001062993-22-005787 · form4.xml · derivative · entry 3 Graves Paul W · CIK 0001559551 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,628 Underlying: Common Stock · 60,628 shares Expires 2032-02-23 F1 · shares: Reflects the grant of stock options to purchase shares of common stock of the Issuer under the Issuer's Incentive Compensation and Stock Plan (the "Plan"). The stock options are scheduled to vest and become exercisable in full on the third anniversary of the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder. The stock options will expire on the tenth anniversary of the date of grant. F1 · derivative.exercise_date: Reflects the grant of stock options to purchase shares of common stock of the Issuer under the Issuer's Incentive Compensation and Stock Plan (the "Plan"). The stock options are scheduled to vest and become exercisable in full on the third anniversary of the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder. The stock options will expire on the tenth anniversary of the date of grant. F1 · derivative.expiration_date: Reflects the grant of stock options to purchase shares of common stock of the Issuer under the Issuer's Incentive Compensation and Stock Plan (the "Plan"). The stock options are scheduled to vest and become exercisable in full on the third anniversary of the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder. The stock options will expire on the tenth anniversary of the date of grant. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 23:33 UTC | Livent Corp. LTHM · Entity 95365 | GrantCommon Stock | 40,457 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-005787 · form4.xml · nonDerivative · entry 1 Graves Paul W · CIK 0001559551 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,980 Read SEC document |
| October 11, 2021 Filed Oct 13, 2021 19:03 UTC | Livent Corp. LTHM · Entity 95365 | Tax withholdingCommon Stock | 23,624 | $23.09 | $545,478.16 |
DisclosureSEC source: 0001879789-21-000005 · edgar.xml · nonDerivative · entry 1 Graves Paul W · CIK 0001559551 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,523 Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 12:29 UTC | LYDALL INC /DE/ LDL · Entity 134982 | Disposition to issuerCommon Stock | 773 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001780989-21-000059 · edgar.xml · nonDerivative · entry 1 Graves Paul W · CIK 0001559551 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Disposed of as a result of the merger pursuant to the previously announced Agreement and Plan of Merger, dated as of June 21, 2021, by and among Lydall, Inc., Unifrax Holding Co., Outback Merger Sub, Inc. and Unifrax I LLC, as it may be amended from time to time, referred to as the Merger Agreement. F2 · price: Each share of common stock was cancelled pursuant to the Merger Agreement in exchange for the right to receive $62.10 in cash per share. Read SEC document |
| April 20, 2021 Filed Apr 22, 2021 08:13 UTC | LYDALL INC /DE/ LDL · Entity 134982 | GrantCommon Stock | 773 | $31.07 | $24,017.11 |
DisclosureSEC source: 0001780989-21-000043 · edgar.xml · nonDerivative · entry 1 Graves Paul W · CIK 0001559551 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 773 F1 · shares: Pursuant to a resolution adopted by the Board of Directors of the Issuer, each non-employee director, upon election to the Board, receives a fully vested and unrestricted stock award on the date they are elected to the Board ("Grant Date") under the Issuer's Amended and Restated 2012 Stock Incentive Plan (the "Plan"). Each stock award consists of that number of whole shares of common stock of the Issuer, subject to adjustment for rounding, equal in value to $24,000, based on the Fair Market Value of the issuer's common stock on the Grant Date. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 20:46 UTC | Livent Corp. LTHM · Entity 95365 | GrantStock Option (Right to Buy) · Derivative | 200,512 | $0.00 Strike: $20.35 | $0.00 |
DisclosureSEC source: 0001192482-21-000170 · edgar.xml · derivative · entry 3 Graves Paul W · CIK 0001559551 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,512 Underlying: Common Stock · 200,512 shares Expires 2031-02-22 Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 20:46 UTC | Livent Corp. LTHM · Entity 95365 | GrantCommon Stock | 57,740 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-21-000170 · edgar.xml · nonDerivative · entry 1 Graves Paul W · CIK 0001559551 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 283,147 Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 20:46 UTC | Livent Corp. LTHM · Entity 95365 | SaleCommon Stock | 3,715 | $20.59 | $76,491.85 |
DisclosureSEC source: 0001192482-21-000166 · edgar.xml · nonDerivative · entry 2 Graves Paul W · CIK 0001559551 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,407 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2020. F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.58 to $20.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 20:46 UTC | Livent Corp. LTHM · Entity 95365 | Tax withholdingCommon Stock | 12,835 | $22.77 | $292,252.95 |
DisclosureSEC source: 0001192482-21-000166 · edgar.xml · nonDerivative · entry 1 Graves Paul W · CIK 0001559551 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,122 Read SEC document |
| January 08, 2021 Filed Jan 11, 2021 21:39 UTC | Livent Corp. LTHM · Entity 95365 | SaleCommon Stock | 4,991 | $22.09 | $110,251.19 |
DisclosureSEC source: 0001192482-21-000048 · edgar.xml · nonDerivative · entry 1 Graves Paul W · CIK 0001559551 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,957 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2020. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 15:39 UTC | Livent Corp. LTHM · Entity 95365 | Tax withholdingCommon Stock | 9,550 | $18.84 | $179,922.00 |
DisclosureSEC source: 0001192482-21-000044 · edgar.xml · nonDerivative · entry 1 Graves Paul W · CIK 0001559551 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,948 Read SEC document |
| March 03, 2020 Filed Mar 5, 2020 18:46 UTC | Livent Corp. LTHM · Entity 95365 | Tax withholdingCommon Stock | 18,157 | $9.73 | $176,667.61 |
DisclosureSEC source: 0001127602-20-009565 · form4.xml · nonDerivative · entry 2 Graves Paul W · CIK 0001559551 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,498 Read SEC document |
| January 10, 2020 Filed Mar 5, 2020 18:46 UTC | Livent Corp. LTHM · Entity 95365 | Tax withholdingCommon Stock | 14,454 | $8.55 | $123,581.70 |
DisclosureSEC source: 0001127602-20-009565 · form4.xml · nonDerivative · entry 1 Graves Paul W · CIK 0001559551 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,655 Read SEC document |
| June 10, 2019 Filed Jun 12, 2019 13:57 UTC | Livent Corp. LTHM · Entity 95365 | OtherCommon Stock | 92,300 | $7.04 | $649,792.00 |
DisclosureSEC source: 0001127602-19-021428 · form4.xml · nonDerivative · entry 1 Graves Paul W · CIK 0001559551 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By NQ Savings Plan Disclosed balance after: 97,815 Read SEC document |
| June 10, 2019 Filed Jun 12, 2019 13:52 UTC | Livent Corp. LTHM · Entity 95365 | OtherCommon Stock | 92,300 | $7.04 | $649,792.00 |
DisclosureSEC source: 0001127602-19-021425 · form4.xml · nonDerivative · entry 1 Graves Paul W · CIK 0001559551 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By NQ Savings Plan Disclosed balance after: 97,815 Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:20 UTC | FMC CORP FMC · Entity 4704 | Disposition to issuerStock Option (Right to Buy) · Derivative | 11,983 | Not disclosed Strike: $85.24 | Not disclosed |
DisclosureSEC source: 0000950103-19-003080 · dp103212_4-gravesfmc.xml · derivative · entry 6 Graves Paul W · CIK 0001559551 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,983 shares Expires 2028-02-15 F2 · shares: Represents the conversion of stock options to purchase FMC Common Stock ("FMC Options") into stock options to purchase Livent Common Stock ("Livent Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. F2 · price: Represents the conversion of stock options to purchase FMC Common Stock ("FMC Options") into stock options to purchase Livent Common Stock ("Livent Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:20 UTC | FMC CORP FMC · Entity 4704 | Disposition to issuerStock Option (Right to Buy) · Derivative | 18,591 | Not disclosed Strike: $57.63 | Not disclosed |
DisclosureSEC source: 0000950103-19-003080 · dp103212_4-gravesfmc.xml · derivative · entry 5 Graves Paul W · CIK 0001559551 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,591 shares Expires 2027-02-27 F2 · shares: Represents the conversion of stock options to purchase FMC Common Stock ("FMC Options") into stock options to purchase Livent Common Stock ("Livent Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. F2 · price: Represents the conversion of stock options to purchase FMC Common Stock ("FMC Options") into stock options to purchase Livent Common Stock ("Livent Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:20 UTC | FMC CORP FMC · Entity 4704 | Disposition to issuerStock Option (Right to Buy) · Derivative | 13,986 | Not disclosed Strike: $63.41 | Not disclosed |
DisclosureSEC source: 0000950103-19-003080 · dp103212_4-gravesfmc.xml · derivative · entry 4 Graves Paul W · CIK 0001559551 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,986 shares Expires 2025-02-27 F2 · shares: Represents the conversion of stock options to purchase FMC Common Stock ("FMC Options") into stock options to purchase Livent Common Stock ("Livent Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. F2 · price: Represents the conversion of stock options to purchase FMC Common Stock ("FMC Options") into stock options to purchase Livent Common Stock ("Livent Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:20 UTC | FMC CORP FMC · Entity 4704 | Disposition to issuerStock Option (Right to Buy) · Derivative | 10,252 | Not disclosed Strike: $72.93 | Not disclosed |
DisclosureSEC source: 0000950103-19-003080 · dp103212_4-gravesfmc.xml · derivative · entry 3 Graves Paul W · CIK 0001559551 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,252 shares Expires 2024-02-17 F2 · shares: Represents the conversion of stock options to purchase FMC Common Stock ("FMC Options") into stock options to purchase Livent Common Stock ("Livent Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. F2 · price: Represents the conversion of stock options to purchase FMC Common Stock ("FMC Options") into stock options to purchase Livent Common Stock ("Livent Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:20 UTC | FMC CORP FMC · Entity 4704 | Disposition to issuerStock Option (Right to Buy) · Derivative | 12,246 | Not disclosed Strike: $59.47 | Not disclosed |
DisclosureSEC source: 0000950103-19-003080 · dp103212_4-gravesfmc.xml · derivative · entry 2 Graves Paul W · CIK 0001559551 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,246 shares Expires 2023-02-18 F2 · shares: Represents the conversion of stock options to purchase FMC Common Stock ("FMC Options") into stock options to purchase Livent Common Stock ("Livent Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. F2 · price: Represents the conversion of stock options to purchase FMC Common Stock ("FMC Options") into stock options to purchase Livent Common Stock ("Livent Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:20 UTC | FMC CORP FMC · Entity 4704 | Disposition to issuerCommon Stock | 14,118 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-19-003080 · dp103212_4-gravesfmc.xml · nonDerivative · entry 1 Graves Paul W · CIK 0001559551 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,087 F1 · shares: Represents the conversion of restricted stock units ("FMC RSUs") with respect to shares of common stock of FMC Corporation ("FMC"), par value $0.10 per share ("FMC Common Stock"), held by the Reporting Person as of March 1, 2019, into restricted stock units with respect to shares of common stock of Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent ("EMA") and the anti-dilution adjustment provisions under the FMC Incentive Compensation and Stock Plan ("FMC Plan"), in connection with the prorata spinoff distribution ("Distribution") by FMC of all of its shares of Livent Common Stock to the holders of record of FMC Common Stock on February 25, 2019. F1 · price: Represents the conversion of restricted stock units ("FMC RSUs") with respect to shares of common stock of FMC Corporation ("FMC"), par value $0.10 per share ("FMC Common Stock"), held by the Reporting Person as of March 1, 2019, into restricted stock units with respect to shares of common stock of Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent ("EMA") and the anti-dilution adjustment provisions under the FMC Incentive Compensation and Stock Plan ("FMC Plan"), in connection with the prorata spinoff distribution ("Distribution") by FMC of all of its shares of Livent Common Stock to the holders of record of FMC Common Stock on February 25, 2019. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:14 UTC | Livent Corp. LTHM · Entity 95365 | GrantStock Option (Right to Buy) · Derivative | 83,342 | Not disclosed Strike: $12.26 | Not disclosed |
DisclosureSEC source: 0000950103-19-003072 · dp103204_4-graves.xml · derivative · entry 7 Graves Paul W · CIK 0001559551 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,342 Underlying: Common Stock · 83,342 shares Expires 2028-02-15 F5 · shares: Represents the grant of stock options to purchase Livent Common Stock ("Livent Options") upon the conversion of stock options to purchase FMC Common Stock ("FMC Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. The Livent Options were granted pursuant to the Livent Plan in a manner intended to preserve the aggregate intrinsic value of the awards, and are generally subject to the same terms and conditions (including vesting, exercise and expiration schedules) as applicable to the corresponding FMC Options. F5 · price: Represents the grant of stock options to purchase Livent Common Stock ("Livent Options") upon the conversion of stock options to purchase FMC Common Stock ("FMC Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. The Livent Options were granted pursuant to the Livent Plan in a manner intended to preserve the aggregate intrinsic value of the awards, and are generally subject to the same terms and conditions (including vesting, exercise and expiration schedules) as applicable to the corresponding FMC Options. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:14 UTC | Livent Corp. LTHM · Entity 95365 | GrantStock Option (Right to Buy) · Derivative | 129,301 | Not disclosed Strike: $8.29 | Not disclosed |
DisclosureSEC source: 0000950103-19-003072 · dp103204_4-graves.xml · derivative · entry 6 Graves Paul W · CIK 0001559551 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,301 Underlying: Common Stock · 129,301 shares Expires 2027-02-27 F5 · shares: Represents the grant of stock options to purchase Livent Common Stock ("Livent Options") upon the conversion of stock options to purchase FMC Common Stock ("FMC Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. The Livent Options were granted pursuant to the Livent Plan in a manner intended to preserve the aggregate intrinsic value of the awards, and are generally subject to the same terms and conditions (including vesting, exercise and expiration schedules) as applicable to the corresponding FMC Options. F5 · price: Represents the grant of stock options to purchase Livent Common Stock ("Livent Options") upon the conversion of stock options to purchase FMC Common Stock ("FMC Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. The Livent Options were granted pursuant to the Livent Plan in a manner intended to preserve the aggregate intrinsic value of the awards, and are generally subject to the same terms and conditions (including vesting, exercise and expiration schedules) as applicable to the corresponding FMC Options. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:14 UTC | Livent Corp. LTHM · Entity 95365 | GrantStock Option (Right to Buy) · Derivative | 97,273 | Not disclosed Strike: $9.12 | Not disclosed |
DisclosureSEC source: 0000950103-19-003072 · dp103204_4-graves.xml · derivative · entry 5 Graves Paul W · CIK 0001559551 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,273 Underlying: Common Stock · 97,273 shares Expires 2025-02-27 F5 · shares: Represents the grant of stock options to purchase Livent Common Stock ("Livent Options") upon the conversion of stock options to purchase FMC Common Stock ("FMC Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. The Livent Options were granted pursuant to the Livent Plan in a manner intended to preserve the aggregate intrinsic value of the awards, and are generally subject to the same terms and conditions (including vesting, exercise and expiration schedules) as applicable to the corresponding FMC Options. F5 · price: Represents the grant of stock options to purchase Livent Common Stock ("Livent Options") upon the conversion of stock options to purchase FMC Common Stock ("FMC Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. The Livent Options were granted pursuant to the Livent Plan in a manner intended to preserve the aggregate intrinsic value of the awards, and are generally subject to the same terms and conditions (including vesting, exercise and expiration schedules) as applicable to the corresponding FMC Options. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:14 UTC | Livent Corp. LTHM · Entity 95365 | GrantStock Option (Right to Buy) · Derivative | 71,303 | Not disclosed Strike: $10.49 | Not disclosed |
DisclosureSEC source: 0000950103-19-003072 · dp103204_4-graves.xml · derivative · entry 4 Graves Paul W · CIK 0001559551 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,303 Underlying: Common Stock · 71,303 shares Expires 2024-02-17 F5 · shares: Represents the grant of stock options to purchase Livent Common Stock ("Livent Options") upon the conversion of stock options to purchase FMC Common Stock ("FMC Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. The Livent Options were granted pursuant to the Livent Plan in a manner intended to preserve the aggregate intrinsic value of the awards, and are generally subject to the same terms and conditions (including vesting, exercise and expiration schedules) as applicable to the corresponding FMC Options. F5 · price: Represents the grant of stock options to purchase Livent Common Stock ("Livent Options") upon the conversion of stock options to purchase FMC Common Stock ("FMC Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. The Livent Options were granted pursuant to the Livent Plan in a manner intended to preserve the aggregate intrinsic value of the awards, and are generally subject to the same terms and conditions (including vesting, exercise and expiration schedules) as applicable to the corresponding FMC Options. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:14 UTC | Livent Corp. LTHM · Entity 95365 | GrantStock Option (Right to Buy) · Derivative | 85,171 | Not disclosed Strike: $8.56 | Not disclosed |
DisclosureSEC source: 0000950103-19-003072 · dp103204_4-graves.xml · derivative · entry 3 Graves Paul W · CIK 0001559551 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,171 Underlying: Common Stock · 85,171 shares Expires 2023-02-18 F5 · shares: Represents the grant of stock options to purchase Livent Common Stock ("Livent Options") upon the conversion of stock options to purchase FMC Common Stock ("FMC Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. The Livent Options were granted pursuant to the Livent Plan in a manner intended to preserve the aggregate intrinsic value of the awards, and are generally subject to the same terms and conditions (including vesting, exercise and expiration schedules) as applicable to the corresponding FMC Options. F5 · price: Represents the grant of stock options to purchase Livent Common Stock ("Livent Options") upon the conversion of stock options to purchase FMC Common Stock ("FMC Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. The Livent Options were granted pursuant to the Livent Plan in a manner intended to preserve the aggregate intrinsic value of the awards, and are generally subject to the same terms and conditions (including vesting, exercise and expiration schedules) as applicable to the corresponding FMC Options. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:14 UTC | Livent Corp. LTHM · Entity 95365 | GrantCommon Stock | 143,075 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-19-003072 · dp103204_4-graves.xml · nonDerivative · entry 1 Graves Paul W · CIK 0001559551 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289,109 F1 · shares: Represents the grant of restricted stock units ("Livent RSUs") with respect to shares of common stock of Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), upon the conversion of restricted stock units with respect to shares of common stock of FMC Corporation ("FMC"), par value $0.10 per share ("FMC Common Stock"), held by the Reporting Person as of March 1, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between Livent and FMC ("EMA") and the anti-dilution adjustment provisions under the FMC Incentive Compensation and Stock Plan ("FMC Plan"), in connection with the prorata spinoff distribution ("Distribution") by FMC of all of its shares of Livent Common Stock to the holders of record of FMC Common Stock on February 25, 2019 ("Record Date"). F2 · shares: The Livent RSUs were granted pursuant to the Livent Corporation Incentive Compensation and Stock Plan ("Livent Plan") in a manner intended to preserve the aggregate intrinsic value of the awards, and are generally subject to the same terms and conditions (including vesting and payment schedules) as applicable to the corresponding FMC restricted stock units. F1 · price: Represents the grant of restricted stock units ("Livent RSUs") with respect to shares of common stock of Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), upon the conversion of restricted stock units with respect to shares of common stock of FMC Corporation ("FMC"), par value $0.10 per share ("FMC Common Stock"), held by the Reporting Person as of March 1, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between Livent and FMC ("EMA") and the anti-dilution adjustment provisions under the FMC Incentive Compensation and Stock Plan ("FMC Plan"), in connection with the prorata spinoff distribution ("Distribution") by FMC of all of its shares of Livent Common Stock to the holders of record of FMC Common Stock on February 25, 2019 ("Record Date"). F2 · price: The Livent RSUs were granted pursuant to the Livent Corporation Incentive Compensation and Stock Plan ("Livent Plan") in a manner intended to preserve the aggregate intrinsic value of the awards, and are generally subject to the same terms and conditions (including vesting and payment schedules) as applicable to the corresponding FMC restricted stock units. F3 · balance_after: Reflects shares of Livent Common Stock received in connection with the Distribution in respect of shares of FMC Common Stock held as of the Record Date. Read SEC document |
| February 20, 2019 Filed Feb 21, 2019 20:34 UTC | FMC CORP FMC · Entity 4704 | GrantCommon Stock | 15 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-007482 · form4.xml · nonDerivative · entry 4 Graves Paul W · CIK 0001559551 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,215 F1 · shares: These shares were issued pursuant to dividend equivalent rights accrued with respect to performance based restricted stock units that were "banked" or vested as of this date. Read SEC document |
| February 20, 2019 Filed Feb 21, 2019 20:34 UTC | FMC CORP FMC · Entity 4704 | GrantCommon Stock | 28 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-007482 · form4.xml · nonDerivative · entry 3 Graves Paul W · CIK 0001559551 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,200 F1 · shares: These shares were issued pursuant to dividend equivalent rights accrued with respect to performance based restricted stock units that were "banked" or vested as of this date. Read SEC document |
| February 20, 2019 Filed Feb 21, 2019 20:34 UTC | FMC CORP FMC · Entity 4704 | GrantCommon Stock | 1,223 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-007482 · form4.xml · nonDerivative · entry 2 Graves Paul W · CIK 0001559551 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,172 Read SEC document |
| February 20, 2019 Filed Feb 21, 2019 20:34 UTC | FMC CORP FMC · Entity 4704 | GrantCommon Stock | 1,331 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-007482 · form4.xml · nonDerivative · entry 1 Graves Paul W · CIK 0001559551 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,949 Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 20:58 UTC | FMC CORP FMC · Entity 4704 | Exercise / conversionStock Option (Right to Buy) · Derivative | 36,175 | $0.00 Strike: $37.38 | $0.00 |
DisclosureSEC source: 0001127602-19-006753 · form4.xml · derivative · entry 4 Graves Paul W · CIK 0001559551 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,175 shares Expires 2026-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 20:58 UTC | FMC CORP FMC · Entity 4704 | Tax withholdingCommon Stock | 25,444 | $84.38 | $2,146,964.72 |
DisclosureSEC source: 0001127602-19-006753 · form4.xml · nonDerivative · entry 2 Graves Paul W · CIK 0001559551 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,618 Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 20:58 UTC | FMC CORP FMC · Entity 4704 | Exercise / conversionCommon Stock | 36,175 | $37.38 | $1,352,221.50 |
DisclosureSEC source: 0001127602-19-006753 · form4.xml · nonDerivative · entry 1 Graves Paul W · CIK 0001559551 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,062 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2019 Filed Feb 15, 2019 20:05 UTC | FMC CORP FMC · Entity 4704 | Tax withholdingCommon Stock | 28,434 | $82.26 | $2,338,980.84 |
DisclosureSEC source: 0001127602-19-006236 · form4.xml · nonDerivative · entry 1 Graves Paul W · CIK 0001559551 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,887 Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 20:39 UTC | FMC CORP FMC · Entity 4704 | GrantCommon Stock | 150 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-004297 · form4.xml · nonDerivative · entry 4 Graves Paul W · CIK 0001559551 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,321 F1 · shares: These shares were issued pursuant to dividend equivalent rights accrued with respect to performance based restricted stock units that were "banked" or vested as of this date. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 20:39 UTC | FMC CORP FMC · Entity 4704 | GrantCommon Stock | 75 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-004297 · form4.xml · nonDerivative · entry 3 Graves Paul W · CIK 0001559551 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,171 F1 · shares: These shares were issued pursuant to dividend equivalent rights accrued with respect to performance based restricted stock units that were "banked" or vested as of this date. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 20:39 UTC | FMC CORP FMC · Entity 4704 | GrantCommon Stock | 4,990 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-004297 · form4.xml · nonDerivative · entry 2 Graves Paul W · CIK 0001559551 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,096 Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 20:39 UTC | FMC CORP FMC · Entity 4704 | GrantCommon Stock | 2,494 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-004297 · form4.xml · nonDerivative · entry 1 Graves Paul W · CIK 0001559551 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,106 Read SEC document |
| October 10, 2018 Filed Oct 12, 2018 20:22 UTC | Livent Corp. LTHM · Entity 95365 | GrantStock Option (right to purchase) · Derivative | 266,667 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0000950103-18-011972 · dp96875_4-graves.xml · derivative · entry 2 Graves Paul W · CIK 0001559551 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,667 Underlying: Common Stock · 266,667 shares Expires not disclosed F2 · shares: Reflects the grant of stock options to purchase shares of common stock of the Issuer under the Plan. The stock options are scheduled to vest and become exercisable 50% on each of the third and fourth anniversaries of the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder. The stock options will expire on the tenth anniversary of the date of grant. F2 · derivative.exercise_date: Reflects the grant of stock options to purchase shares of common stock of the Issuer under the Plan. The stock options are scheduled to vest and become exercisable 50% on each of the third and fourth anniversaries of the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder. The stock options will expire on the tenth anniversary of the date of grant. F2 · derivative.expiration_date: Reflects the grant of stock options to purchase shares of common stock of the Issuer under the Plan. The stock options are scheduled to vest and become exercisable 50% on each of the third and fourth anniversaries of the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder. The stock options will expire on the tenth anniversary of the date of grant. Read SEC document |
| October 10, 2018 Filed Oct 12, 2018 20:22 UTC | Livent Corp. LTHM · Entity 95365 | GrantCommon Stock | 82,353 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-18-011972 · dp96875_4-graves.xml · nonDerivative · entry 1 Graves Paul W · CIK 0001559551 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,353 F1 · shares: Reflects the grant of restricted stock units under the Issuer's Incentive Compensation and Stock Plan (the "Plan"), which are scheduled to vest 50% on each of the third and fourth anniversaries of the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder. Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 15:03 UTC | FMC CORP FMC · Entity 4704 | SaleCommon Stock | 3,615 | $88.46 | $319,782.90 |
DisclosureSEC source: 0001127602-18-020438 · form4.xml · nonDerivative · entry 1 Graves Paul W · CIK 0001559551 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,612 F1 · price: Represents the weighted average sales price for price increments ranging from $88.33 to $88.57. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 15:29 UTC | FMC CORP FMC · Entity 4704 | Tax withholdingCommon Stock | 1,756 | $83.65 | $146,889.40 |
DisclosureSEC source: 0001127602-18-009249 · form4.xml · nonDerivative · entry 1 Graves Paul W · CIK 0001559551 · Exec VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,227 Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 20:43 UTC | FMC CORP FMC · Entity 4704 | GrantStock Option (Right to Buy) · Derivative | 11,983 | $0.00 Strike: $85.24 | $0.00 |
DisclosureSEC source: 0001127602-18-007122 · form4.xml · derivative · entry 7 Graves Paul W · CIK 0001559551 · Exec VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,983 Underlying: Common Stock · 11,983 shares Expires 2028-02-15 Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 20:43 UTC | FMC CORP FMC · Entity 4704 | GrantCommon Stock | 21 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-007122 · form4.xml · nonDerivative · entry 5 Graves Paul W · CIK 0001559551 · Exec VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,983 F1 · shares: These shares were issued pursuant to dividend equivalent rights accrued with respect to performance based restricted stock units that were "banked" as of this date. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 20:43 UTC | FMC CORP FMC · Entity 4704 | GrantCommon Stock | 70 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-007122 · form4.xml · nonDerivative · entry 4 Graves Paul W · CIK 0001559551 · Exec VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,962 F1 · shares: These shares were issued pursuant to dividend equivalent rights accrued with respect to performance based restricted stock units that were "banked" as of this date. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 20:43 UTC | FMC CORP FMC · Entity 4704 | GrantCommon Stock | 2,892 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-007122 · form4.xml · nonDerivative · entry 3 Graves Paul W · CIK 0001559551 · Exec VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,892 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.